For example, upregulated TRPM7 in pancreatic [185,186], breast [158], ovarian [187], and bladder [188] cancers is correlated with tumour progression and aggression as well as poor overall survival of cancer patients, suggesting a protumour effect of TRPM7. Here, TRPM7 is linked to cancer.